HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Capasso Selected Research

Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)

3/2009Beta-endorphin fragments DTgammaE and DEgammaE reduced morphine inhibition of electrically-induced contractions and opiate withdrawal.
7/2007The effect of flavonol glycosides on opiate withdrawal.
8/2003The effect of papaverine on acute opiate withdrawal in guinea pig ileum.
2/2002Beta-endorphin fragments (DT gamma E and DE gamma E) reduce opiate withdrawal in guinea pig ileum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Capasso Research Topics

Disease

46Neoplasms (Cancer)
02/2022 - 10/2010
11Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 10/2010
7Contracture
05/2009 - 02/2002
5Melanoma (Melanoma, Malignant)
01/2021 - 10/2011
5Triple Negative Breast Neoplasms
11/2020 - 01/2017
5Feeding and Eating Disorders (Eating Disorder)
01/2020 - 01/2009
4Breast Neoplasms (Breast Cancer)
06/2016 - 10/2011
3Obesity
06/2020 - 01/2013
3Colonic Neoplasms (Colon Cancer)
12/2013 - 10/2011
3Body Weight (Weight, Body)
11/2010 - 11/2006
3Overweight
11/2010 - 11/2006
2Carcinoma (Carcinomatosis)
02/2022 - 11/2013
2Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2018
2Aneuploidy (Aneuploid)
11/2019 - 10/2018
2Disease Progression
01/2018 - 01/2017
2Metabolic Diseases (Metabolic Disease)
01/2018 - 01/2013
2Hypertension (High Blood Pressure)
01/2018 - 01/2013
2Hyperprolactinemia
01/2017 - 01/2011
2Schizophrenia (Dementia Praecox)
01/2017 - 01/2016
2Neoplasm Metastasis (Metastasis)
01/2016 - 01/2013
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013 - 08/2010
2Migraine Disorders (Migraine)
01/2012 - 10/2009
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022
1Thrombotic Microangiopathies
01/2022
1Cytopenia
01/2022
1Chronic Renal Insufficiency
01/2022
1Iron Deficiencies
01/2022
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
12/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Diabetes Mellitus
08/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
02/2020

Drug/Important Bio-Agent (IBA)

8Naloxone (Narcan)FDA LinkGeneric
11/2010 - 02/2002
8Morphine (MS Contin)FDA LinkGeneric
05/2009 - 02/2002
7Phosphotransferases (Kinase)IBA
10/2018 - 11/2013
6Biomarkers (Surrogate Marker)IBA
02/2022 - 03/2011
5Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2009
5Pharmaceutical PreparationsIBA
01/2018 - 04/2008
5Opioid Analgesics (Opioids)IBA
03/2009 - 02/2002
4Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
4Glucose (Dextrose)FDA LinkGeneric
08/2020 - 08/2010
4Biological ProductsIBA
02/2020 - 01/2017
4EndocannabinoidsIBA
01/2018 - 10/2012
4Neurotransmitter Agents (Neurotransmitter)IBA
01/2018 - 01/2009
4Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA
03/2009 - 02/2002
3CytokinesIBA
01/2021 - 01/2020
3regorafenibIBA
10/2018 - 11/2013
3ENMD 2076IBA
10/2018 - 01/2017
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018 - 11/2013
3Hormones (Hormone)IBA
01/2018 - 08/2010
3Messenger RNA (mRNA)IBA
01/2018 - 08/2010
3CannabinoidsIBA
01/2018 - 01/2016
3Antipsychotic Agents (Antipsychotics)IBA
01/2017 - 01/2011
3Cetuximab (Erbitux)FDA Link
07/2014 - 10/2010
3DNA (Deoxyribonucleic Acid)IBA
04/2014 - 04/2012
3ErbB Receptors (EGF Receptor)IBA
12/2013 - 10/2010
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2012 - 11/2011
3Adrenocorticotropic Hormone (ACTH)FDA Link
11/2010 - 11/2006
3CorticosteroneIBA
11/2010 - 11/2006
2CateninsIBA
11/2020 - 11/2019
2RX-5902IBA
11/2020 - 11/2019
2EverolimusFDA Link
01/2020 - 11/2013
2MLN 8237IBA
01/2020 - 08/2016
2Bevacizumab (Avastin)FDA Link
01/2018 - 01/2013
2Docosahexaenoic AcidsIBA
01/2018 - 06/2016
2Eicosapentaenoic AcidIBA
01/2018 - 06/2016
2Irinotecan (Camptosar)FDA LinkGeneric
01/2018 - 05/2016
2Estrogens (Estrogen)FDA Link
01/2018 - 01/2015
2Peptides (Polypeptides)IBA
01/2018 - 01/2009
2Monoclonal AntibodiesIBA
01/2018 - 12/2013
2carbazoleIBA
01/2015 - 01/2015
2AntibodiesIBA
07/2014 - 01/2013
2Sorafenib (BAY 43-9006)FDA Link
11/2013 - 10/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013 - 10/2010
2LipidsIBA
01/2013 - 10/2012
2Vinorelbine (Navelbine)FDA LinkGeneric
07/2012 - 07/2011
2GlycosidesIBA
01/2012 - 07/2007
2Complex MixturesIBA
11/2011 - 10/2011
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
08/2010 - 11/2006
2des-enkephalin-gamma-endorphinIBA
03/2009 - 02/2002
2des-Tyr(1)- gamma-endorphinIBA
03/2009 - 02/2002
2deltorphinIBA
03/2009 - 02/2002
2beta-Endorphin (Endorphin, beta)IBA
03/2009 - 02/2002
2Opiate AlkaloidsIBA
07/2007 - 08/2003
1MicroRNAs (MicroRNA)IBA
02/2022
1nusinersenIBA
01/2022
1Circulating Tumor DNAIBA
12/2021
1Untranslated RNA (Noncoding RNA)IBA
12/2021
1LycopeneIBA
09/2021

Therapy/Procedure

17Therapeutics
01/2022 - 02/2011
6Immunotherapy
01/2021 - 01/2016
2Kidney Transplantation
01/2022 - 07/2020
2Transplantation
01/2022 - 07/2020
2Operative Surgical Procedures
01/2022 - 01/2013
2Drug Therapy (Chemotherapy)
01/2020 - 04/2008
2Aftercare (After-Treatment)
01/2017 - 03/2009
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2022
1Patient Transfer (Patient Dumping)
10/2021